This is especially applicable to the funding of insulins (Type 1 and 2 diabetes) as well as an appreciable number of medicines for instance that Type 2 diabetes patients may be prescribed to help control their diabetes and associated complications including oral anti-diabetic agents (one or two including metformin), multiple antihypertensives, statins, low dose aspirin, etc. Here, INS is linked to type 2 diabetes mellitus.